Click on one of these terms to refine your search
1 to 3 of 3 literature results
Bexarotene is approved for the treatment of cutaneous T cell lymphomas in patients refractory to at least one prior systemic therapy. Associated hyper…
Authors: Antonino Musolino, Michele Panebianco, Enrico Zendri, Marcello Santini, Sergio Di Nuzzo, Andrea Ardizzoni
Source: British journal of haematology. 2009 Apr
View Full TextBACKGROUND: Some dermatopathological parameters are recognized as dominant indicators of high metastatic potential in melanoma, especially Breslow thi…
Authors: Donata Ferrari, Mara Lombardi, Roberto Ricci, Maria Michiara, Marcello Santini, Giuseppe De Panfilis
Source: Journal of cutaneous pathology. 2007 Sep
View Full TextAlthough tumor-infiltrating lymphocytes (TILs) of primary cutaneous melanoma (PCM) include cytolytic T cells able to exert anti-PCM immunity, progress…
Authors: Giuseppe De Panfilis, Nicoletta Campanini, Marcello Santini, Giovanni Mori, Elena Tognetti, Roberta Maestri, Mara Lombardi, Elisabetta Froio, Donata Ferrari, Roberto Ricci
Source: The Journal of investigative dermatology. 2008 Mar
View Full Text